WEREWOLF THERAPEUTICS INC's ticker is HOWL and the CUSIP is 95075A107. A total of 38 filers reported holding WEREWOLF THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 589,102 | $1,531,665 | 35.68% |
| MPM ASSET MANAGEMENT LLC | 4,284,172 | $11,138,847 | 4.64% |
| MPM BioImpact LLC | 2,388,011 | $6,208,829 | 1.61% |
| RA Capital Management | 6,144,881 | $15,976,691 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 626,810 | $1,629,706 | 0.27% |
| PFM Health Sciences, LP | 2,217,220 | $5,764,772 | 0.26% |
| Rubric Capital Management LP | 1,935,357 | $5,031,928 | 0.13% |
| Laurion Capital Management LP | 522,900 | $1,359,540 | 0.01% |
| Alyeska Investment Group, L.P. | 397,808 | $1,034,301 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 81,711 | $212,449 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,000,597 | $2,601,552 | 0.01% |
| HBK Sorce Advisory LLC | 26,454 | $68,781 | 0.00% |
| BAILARD, INC. | 18,127 | $47,130 | 0.00% |
| Schonfeld Strategic Advisors LLC | 73,418 | $190,886 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,097,348 | $2,853 | 0.00% |
| MARSHALL WACE, LLP | 120,936 | $314,433 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 78,671 | $203 | 0.00% |
| MORGAN STANLEY | 2,500 | $6,500 | 0.00% |
| BlackRock Inc. | 38,994 | $101,385 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,524 | $4 | 0.00% |
External links
This page lists WEREWOLF THERAPEUTICS INC's shareholders in Q1 2023. To view WEREWOLF THERAPEUTICS INC's shareholder history, click here.